My colleague is sure to have caught your eye by talking about the Banks being likely to benefit from a UK interest rate rise by year-end. So it’s my turn to look the other way and discuss who might suffer. Banks profitability might indeed get a boost from being able to lend out money more…
It’s no surprise to see the likes of Randgold Resources and Fresnillo among the best performers this week, up 5%. Nor to see Rio Tinto and Glencore down 5%. Not when two of the world’s more unpredictable leaders are trading insults and nuclear threats. However, this wasn’t the only story in town this week. There was…
One of the biggest dividend days for the UK Index this year looms large next Thursday. Big names like BT, Anglo American, BP, Royal Dutch Shell, GlaxoSmithKline, AstraZeneca, Diageo, Lloyds and many more are paying anywhere up to 3.3%*. Here’s how not to miss out. With some spectacular moves among UK Index blue-chips lately, often…
AstraZeneca’s Mystic drug trial failure and 15% share price drop (biggest ever fall) has understandably hogged this week’s headlines. And this means that the performance of a key sector – a retail investor favourite – has slipped under the radar, despite rather impressive gains of 3-12%, easily outperforming the UK 100 index of blue-chips which…
This week the UK 100 broke back out of its 2-week sideways channel, giving bulls hope of a return to record highs. The index may only close the week 0.3% higher but blue-chip traders benefited from attractive share price moves of +/- 7%. As we write, the index has potential to see prior resistance turn…
We look set for a flat UK Index finish this week, however this masks the exciting gains and then declines for Miners and Oil (and gains for housebuilders and financials). Which is great for those who missed out, as it offers another bite at the uptrend cherry next week. Especially with the index still holding…